K936112

Substantially Equivalent

STREP B OIA

Applicant: Biostar, Inc.
Product code: GTY
Advisory panel: Microbiology
Date received: 1993-12-23
Decision date: 1994-07-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Boulder, CO, US

Adverse events under product code GTY

product code GTY

Death: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.